The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China

BACKGROUND: Great success has been made in the targeting therapy of advanced non-small cell lung cancer (NSCLC). Nowadays, next generation sequencing (NGS) is acquirable and affordable in developed area of China. Using this feasible and accurate method of detecting therapeutic genes would help to se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Shen, Wen-Xiang, Zhou, Li-Na, Tang, Min, Tan, Yue, Feng, Chun-Xia, Li, Ping, Wang, Li-Qiang, Chen, Min-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003276/
https://www.ncbi.nlm.nih.gov/pubmed/32047821
http://dx.doi.org/10.1155/2020/9387167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003276/
https://www.ncbi.nlm.nih.gov/pubmed/32047821
http://dx.doi.org/10.1155/2020/9387167

Ejemplares similares